Published in Nature on September 15, 1988
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood (2005) 6.16
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med (1990) 3.59
Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J Virol (1991) 3.24
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med (1991) 3.03
Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol (2009) 2.70
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med (2000) 2.69
FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo. Blood (2008) 2.31
The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol (2008) 2.21
Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med (1991) 2.20
Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol (2010) 2.19
HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood (2007) 2.10
Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med (1989) 1.77
Mice with human immune system components as in vivo models for infections with human pathogens. Immunol Cell Biol (2011) 1.75
Lymphomas differ in their dependence on Epstein-Barr virus. Blood (2010) 1.74
Animal models for HIV/AIDS research. Nat Rev Microbiol (2012) 1.71
Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol (2013) 1.70
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc Natl Acad Sci U S A (1995) 1.69
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol (2008) 1.68
In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A (1992) 1.67
Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med (1992) 1.65
Current advances in humanized mouse models. Cell Mol Immunol (2012) 1.65
Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med (1990) 1.61
Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J Exp Med (1999) 1.61
Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin Immunopathol (2010) 1.58
Renaissance for mouse models of human hematopoiesis and immunobiology. Nat Immunol (2009) 1.54
Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice. Hum Immunol (2009) 1.53
Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc Natl Acad Sci U S A (1993) 1.50
Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest (1990) 1.49
Humanized mouse models of HIV infection. AIDS Rev (2011) 1.49
Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol (1995) 1.49
Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology. Am J Pathol (1990) 1.48
Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes (2010) 1.48
Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed. J Immune Based Ther Vaccines (2004) 1.46
The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. Retrovirology (2011) 1.42
The utilization of humanized mouse models for the study of human retroviral infections. Retrovirology (2009) 1.42
Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One (2011) 1.41
Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome. Antimicrob Agents Chemother (1989) 1.40
Novel humanized murine models for HIV research. Curr HIV/AIDS Rep (2009) 1.40
Are T cells the only HIV-1 reservoir? Retrovirology (2016) 1.39
Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci U S A (1994) 1.36
Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine. Proc Natl Acad Sci U S A (1992) 1.35
Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J Clin Invest (1991) 1.32
Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras. J Exp Med (1994) 1.29
Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest (1992) 1.28
A model for personalized in vivo analysis of human immune responsiveness. Sci Transl Med (2012) 1.27
Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice. J Immunol (2012) 1.27
Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J Virol (1993) 1.26
The Epstein-Barr virus and its association with human cancers. Mol Pathol (1999) 1.26
A model of human immunodeficiency virus encephalitis in scid mice. Proc Natl Acad Sci U S A (1993) 1.25
Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Exp Hematol (2007) 1.25
Giant cell vasculitis is a T cell-dependent disease. Mol Med (1997) 1.23
Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood (2012) 1.23
Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain. J Virol (1997) 1.23
Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J Virol (1995) 1.21
Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals. Proc Natl Acad Sci U S A (1995) 1.17
Humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year. Virology (2009) 1.16
Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech (2011) 1.16
Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγ null mice is enhanced by transgenic expression of membrane-bound human SCF. Blood (2012) 1.16
The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes. J Virol (1998) 1.15
Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model. J Virol (2001) 1.15
Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. J Virol (1995) 1.14
Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells. Clin Exp Immunol (2013) 1.13
Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines. Blood (2008) 1.12
Humanized mice for the study of type 1 diabetes and beta cell function. Ann N Y Acad Sci (2008) 1.11
Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis. Immunol Res (2008) 1.11
PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads. PLoS One (2013) 1.09
CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol (1994) 1.09
Humanized Rag1-/- γc-/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes. PLoS One (2011) 1.09
Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods (2014) 1.08
Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease. Clin Exp Immunol (2011) 1.07
Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. J Clin Invest (2010) 1.06
Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J Exp Med (1992) 1.06
Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci (1994) 1.06
Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient? Regen Med (2011) 1.03
HIV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol (2012) 1.03
Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints. J Clin Invest (1995) 1.02
Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats. J Virol (1991) 1.01
Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice. Proc Natl Acad Sci U S A (1992) 0.99
Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. Am J Pathol (1990) 0.99
Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils. Clin Exp Immunol (1991) 0.99
Mouse models with human immunity and their application in biomedical research. J Cell Mol Med (2008) 0.99
Development of a humanized mouse model to study the role of macrophages in allograft injury. Transplantation (2009) 0.98
Humanized hemato-lymphoid system mice. Haematologica (2016) 0.98
Host specificity of bacterial pathogens. Cold Spring Harb Perspect Med (2013) 0.97
Use of nonobese diabetic mice to understand human type 1 diabetes. Endocrinol Metab Clin North Am (2010) 0.97
The SCID mouse: relevance as an animal model system for studying human disease. Am J Pathol (1993) 0.97
Establishing humanized mice using stem cells: maximizing the potential. Clin Exp Immunol (2008) 0.97
Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells. Cell Stress Chaperones (2002) 0.96
Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol (1991) 0.95
Experimental infection of severe combined immunodeficient beige mice with Mycobacterium paratuberculosis of bovine origin. Infect Immun (1992) 0.95
E-box-independent regulation of transcription and differentiation by MYC. Nat Cell Biol (2011) 0.95
Overcoming current limitations in humanized mouse research. J Infect Dis (2013) 0.95
Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1994) 0.94
Predicting coiled coils by use of pairwise residue correlations. Proc Natl Acad Sci U S A (1995) 5.94
Quantitative studies on the mixed lymphocyte interaction in rats. 3. Kinetics of the response. J Exp Med (1968) 4.52
Acute and subacute rehabilitation for stroke: a comparison. Arch Phys Med Rehabil (1995) 4.20
Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol (1993) 4.13
The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis. Am Psychol (1993) 4.10
Quantitative studies on the mixed lymphocyte interaction in rats. II. Relationship of the proliferative response to the immunologic status of the donors. J Exp Med (1967) 3.82
The metabolism of phosphoinositide-derived messenger molecules. Science (1986) 3.58
Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J Exp Med (1977) 3.30
Quantitative studies on the mixed lymphocyte interaction in rats. I. Conditions and parameters of response. J Exp Med (1967) 3.20
Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat Med (1998) 2.90
Human immunodeficiency virus infection of human-PBL-SCID mice. Science (1991) 2.77
Lymphocytes and transplantation immunity. Adv Immunol (1967) 2.73
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity (1999) 2.67
Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J Immunol (1980) 2.54
Structure and mechanism of endo/exocellulase E4 from Thermomonospora fusca. Nat Struct Biol (1997) 2.49
Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J Immunol (2001) 2.39
Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem (1992) 2.35
Origin of immunoreactive lymphocytes in rats. Cell Immunol (1970) 2.30
Collaboration of allogeneic T and B lymphocytes in the primary antibody response to sheep erythrocytes in vitro. J Exp Med (1975) 2.30
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J Virol (1999) 2.20
Targeted mutagenesis of the transcription factor GATA-4 gene in mouse embryonic stem cells disrupts visceral endoderm differentiation in vitro. Development (1995) 2.19
Stereoselective hydrolysis catalyzed by related beta-1,4-glucanases and beta-1,4-xylanases. J Biol Chem (1992) 2.10
Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr (1999) 2.08
Quantitative studies on the mixed lymphocyte interaction in rats. V. Tempo and specificity of the proliferative response and the number of reactive cells from immunized donors. J Exp Med (1971) 2.04
Regulation of the gal operon of Escherichia coli by the capR gene. J Biol Chem (1972) 2.03
Activity studies of eight purified cellulases: Specificity, synergism, and binding domain effects. Biotechnol Bioeng (1993) 2.01
Localization of transcription factor GATA-4 to regions of the mouse embryo involved in cardiac development. Dev Biol (1994) 2.00
Mixed leukocyte reactions and histocompatibility in rats. Science (1967) 1.99
Isolation and characterization of the inositol cyclic phosphate products of polyphosphoinositide cleavage by phospholipase C. Physiological effects in permeabilized platelets and Limulus photoreceptor cells. J Biol Chem (1985) 1.98
Specific positive selection of lymphocytes reactive to strong histocompatibility antigens. J Exp Med (1974) 1.98
Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science (1993) 1.97
Cloning of the Thermomonospora fusca Endoglucanase E2 Gene in Streptomyces lividans: Affinity Purification and Functional Domains of the Cloned Gene Product. Appl Environ Microbiol (1988) 1.96
Cellular transport mechanisms. Annu Rev Biochem (1978) 1.94
Identification of two functionally different classes of exocellulases. Biochemistry (1996) 1.93
Quantitative studies on the mixed lymphocyte interaction in rats. IV. Immunologic potentiality of the responding cells. J Exp Med (1970) 1.86
Evidence for the existence of multipotential lympho-hematopoietic stem cells in adult rat. J Cell Physiol (1970) 1.86
Cloning, expression and characterization of a family 48 exocellulase, Cel48A, from Thermobifida fusca. Eur J Biochem (2000) 1.85
The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA (1995) 1.79
Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance. Curr Mol Med (2005) 1.78
Is there a causal relationship between alcohol use and violence? A synthesis of evidence. Recent Dev Alcohol (1997) 1.78
The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens. J Exp Med (1977) 1.75
DNA sequences of three beta-1,4-endoglucanase genes from Thermomonospora fusca. J Bacteriol (1991) 1.74
Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency. Proc Natl Acad Sci U S A (1989) 1.74
Phosphoinositide interconversion in thrombin-stimulated human platelets. J Biol Chem (1985) 1.74
Effect of labor analgesia on breastfeeding success. Birth (1999) 1.73
Wild-type endoderm abrogates the ventral developmental defects associated with GATA-4 deficiency in the mouse. Dev Biol (1997) 1.70
The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells. Mol Cell Biol (1994) 1.70
Source of energy for the Escherichia coli galactose transport systems induced by galactose. J Bacteriol (1974) 1.68
Immunological studies of T-cell receptors. I. Specifically induced resistance to graft-versus-host disease in rats mediated by host T-cell immunity to alloreactive parental T cells. J Exp Med (1978) 1.68
Evaluating food fortification options: general principles revisited with folic acid. Am J Public Health (1995) 1.66
Emergency care and the patient in the long-term care facility. CMAJ (1991) 1.65
Roles of the catalytic domain and two cellulose binding domains of Thermomonospora fusca E4 in cellulose hydrolysis. J Bacteriol (1998) 1.65
Characterization and sequence of a Thermomonospora fusca xylanase. Appl Environ Microbiol (1994) 1.63
Use of a modified Bacteroides-Prevotella shuttle vector to transfer a reconstructed beta-1,4-D-endoglucanase gene into Bacteroides uniformis and Prevotella ruminicola B(1)4. Appl Environ Microbiol (1996) 1.62
Sheep red blood cell-specific helper activity in rat thoracic duct lymphocyte populations positively selected for reactivity to specific strong histocompatibility alloantigens. J Exp Med (1976) 1.62
Crystal structure of the catalytic domain of a thermophilic endocellulase. Biochemistry (1993) 1.61
Hydrolysis of polyphosphoinositides by purified sheep seminal vesicle phospholipase C enzymes. J Biol Chem (1984) 1.60
Identification of a novel Drosophila opsin reveals specific patterning of the R7 and R8 photoreceptor cells. Neuron (1996) 1.59
GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am J Med Genet (1999) 1.59
Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J Immunol (1983) 1.58
DNA sequences and expression in Streptomyces lividans of an exoglucanase gene and an endoglucanase gene from Thermomonospora fusca. Appl Environ Microbiol (1993) 1.57
Production of phosphoinositide-derived messengers. Cell (1984) 1.54
Cloning and sequencing of a Bacteroides ruminicola B(1)4 endoglucanase gene. J Bacteriol (1990) 1.53
Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. Proc Natl Acad Sci U S A (1998) 1.50
Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc Natl Acad Sci U S A (1993) 1.50
Inositol cyclic phosphates are produced by cleavage of phosphatidylphosphoinositols (polyphosphoinositides) with purified sheep seminal vesicle phospholipase C enzymes. Proc Natl Acad Sci U S A (1985) 1.49
Immunological studies of T-cell receptors. II. Limited polymorphism of idiotypic determinants on T-cell receptors specific for major histocompatibility complex alloantigens. J Exp Med (1979) 1.47
Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats. J Exp Med (1986) 1.46
Distinct roles for visceral endoderm during embryonic mouse development. Int J Dev Biol (1999) 1.44
The NH2-terminal sequences of galactokinase from Escherichia coli and Saccharomyces cerevisiae. FEBS Lett (1977) 1.43
Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology (1999) 1.42
The regulation and properties of the galactose transport system in Escherichia coli K12. J Biol Chem (1974) 1.40
Amnesic action of midazolam. Anaesthesia (1980) 1.39
SPECIFIC positive and negative selection of rat lymphocytes reactive to strong histocompatibility antigens: activation with alloantigens in vitro and in vivo. J Immunol (1976) 1.38
Studies on the life history of lymphocytes. I. The life-span of cells responsive in the mixed lymphocyte interaction. J Exp Med (1971) 1.36
Discovery of an arachidonoyl coenzyme A synthetase in human platelets. J Biol Chem (1982) 1.36
The way in which intervention studies have "personality" and why it is important to meta-analysis. Eval Health Prof (2001) 1.36
Protein chain initiation in rabbit reticulocytes. Proc Natl Acad Sci U S A (1970) 1.35
Construction and characterization of Escherichia coli genetically engineered for bioremediation of Hg(2+)-contaminated environments. Appl Environ Microbiol (1997) 1.33
Histocompatibility antigen-activated cytotoxic T lymphocytes. I. Estimates of the absolute frequency of killer cells generated in vitro. J Exp Med (1977) 1.33
Typing and immunosuppression in rats. Transplantation (1967) 1.31
Identification of a celE-binding protein and its potential role in induction of the celE gene in Thermomonospora fusca. J Bacteriol (1988) 1.30
Effect of the lambda S gene product on properties of the Escherichia coli inner membrane. J Bacteriol (1982) 1.29
Fourth branchial pouch sinus: principles of diagnosis and management. Laryngoscope (1990) 1.29
Cloning of a Thermomonospora fusca xylanase gene and its expression in Escherichia coli and Streptomyces lividans. J Bacteriol (1989) 1.29
Regulation of beta-1,4-Endoglucanase Synthesis in Thermomonospora fusca. Appl Environ Microbiol (1987) 1.28
Characterization of a Thermomonospora fusca exocellulase. Biochemistry (1995) 1.28
Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr Opin Immunol (1999) 1.27
Isolation and characterization of the inositol cyclic phosphate products of phosphoinositide cleavage by phospholipase C. Metabolism in cell-free extracts. J Biol Chem (1986) 1.25
Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology (1997) 1.25
Oligomerization of the bacteriophage lambda S protein in the inner membrane of Escherichia coli. J Bacteriol (1990) 1.25
Some biological aspects of lymphocytes reactive to strong histocompatibility alloantigens. Transplant Rev (1972) 1.24
Chorismate mutase-prephenate dehydratase from Escherichia coli. Study of catalytic and regulatory domains using genetically engineered proteins. J Biol Chem (1998) 1.24
A Bacteroides ruminicola 1,4-beta-D-endoglucanase is encoded in two reading frames. J Bacteriol (1991) 1.23
Fgf-8 expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system. Mech Dev (1994) 1.22
Cardiomyocyte differentiation by GATA-4-deficient embryonic stem cells. Development (1997) 1.22